Twist Bioscience Corp Stock Analysis

Twist Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.6. Twist Bioscience Corp had not issued any dividends in recent years. Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company was incorporated in 2013 and is headquartered in South San Francisco, California. Twist Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 989 people. To find out more about Twist Bioscience Corp contact Emily Leproust at 800 719 0671 or learn more at https://www.twistbioscience.com.

Twist Bioscience Corp Investment Alerts

Twist Bioscience Corp Upcoming and Recent Events

Twist Largest EPS Surprises

View All Earnings Estimates

Twist Bioscience Environmental, Social, and Governance (ESG) Scores

Twist Stock Institutional Investors

Note, although Twist Bioscience's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Twist Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.59 B.

Twist Profitablity

The company has Profit Margin (PM) of (0.75) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.54) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.54.

Management Efficiency

Twist Bioscience Corp has return on total asset (ROA) of (0.1639) % which means that it has lost $0.1639 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3836) %, meaning that it created substantial loss on money invested by shareholders. Twist Bioscience's management efficiency ratios could be used to measure how well Twist Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.43 in 2024. Return On Capital Employed is likely to drop to -0.43 in 2024. Non Current Liabilities Total is likely to gain to about 86.5 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 49 M in 2024.

Technical Drivers

As of the 20th of December, Twist Bioscience has the Variance of 14.58, risk adjusted performance of (0.0009), and Coefficient Of Variation of (8,997). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Twist Bioscience Corp, as well as the relationship between them.

Twist Bioscience Corp Price Movement Analysis

Twist Bioscience Corp Insider Trading Activities

Twist Bioscience Outstanding Bonds

Twist Bioscience Predictive Daily Indicators

Twist Bioscience Corporate Filings

Twist Bioscience Forecast Models

Twist Bioscience's time-series forecasting models are one of many Twist Bioscience's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Twist Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Twist Bioscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Twist shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Twist Bioscience. By using and applying Twist Stock analysis, traders can create a robust methodology for identifying Twist entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Twist analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Twist analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Twist Bioscience Corp stock analysis indicators help investors evaluate how Twist Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Twist Bioscience shares will generate the highest return on investment. By understating and applying Twist Bioscience stock analysis, traders can identify Twist Bioscience position entry and exit signals to maximize returns.

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.